ML Slevin

1.5k total citations · 1 hit paper
11 papers, 1.2k citations indexed

About

ML Slevin is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, ML Slevin has authored 11 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Reproductive Medicine and 2 papers in Surgery. Recurrent topics in ML Slevin's work include Ovarian cancer diagnosis and treatment (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Cancer survivorship and care (2 papers). ML Slevin is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Cancer survivorship and care (2 papers). ML Slevin collaborates with scholars based in United Kingdom, New Zealand and Austria. ML Slevin's co-authors include Jessica Drinkwater, Denis J. Lynch, Hilary Plant, Simran Malik, P. F. M. Wrigley, J S Tobias, R L Souhami, TA Lister, Michel Seymour and JaneMaree Maher and has published in prestigious journals such as British Journal of Cancer.

In The Last Decade

ML Slevin

11 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Who should measure quality of life, the doctor or the patient?

1988 743 citations ML Slevin, Hilary Plant et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
ML Slevin United Kingdom	11	476	241	190	187	185	11	1.2k
Martin Levitt Canada	18	847 1.8×	312 1.3×	137 0.7×	315 1.7×	278 1.5×	36	1.8k
D. Dalley Australia	16	858 1.8×	247 1.0×	103 0.5×	228 1.2×	213 1.2×	35	1.5k
Denise M. Oleske United States	22	510 1.1×	490 2.0×	171 0.9×	270 1.4×	188 1.0×	53	1.8k
James Holland United States	6	640 1.3×	249 1.0×	206 1.1×	194 1.0×	128 0.7×	6	1.3k
Eva Greimel Austria	14	587 1.2×	274 1.1×	194 1.0×	187 1.0×	151 0.8×	20	1.1k
Marianne Steding‐Jessen Denmark	22	626 1.3×	162 0.7×	125 0.7×	151 0.8×	181 1.0×	38	1.3k
Amélie Anota France	17	530 1.1×	172 0.7×	148 0.8×	150 0.8×	158 0.9×	111	1.2k
M. Stead United Kingdom	15	732 1.5×	242 1.0×	210 1.1×	183 1.0×	121 0.7×	17	1.3k
Johan Ahlgren Sweden	23	1.0k 2.1×	281 1.2×	148 0.8×	255 1.4×	151 0.8×	68	1.7k
Harvey Schipper Canada	14	888 1.9×	328 1.4×	224 1.2×	368 2.0×	202 1.1×	34	1.7k

Countries citing papers authored by ML Slevin

Since Specialization

Citations

This map shows the geographic impact of ML Slevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ML Slevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ML Slevin more than expected).

Fields of papers citing papers by ML Slevin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ML Slevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ML Slevin. The network helps show where ML Slevin may publish in the future.

Co-authorship network of co-authors of ML Slevin

This figure shows the co-authorship network connecting the top 25 collaborators of ML Slevin. A scholar is included among the top collaborators of ML Slevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ML Slevin. ML Slevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Slevin, ML, Patrick B. Wilson, TA Lister, et al.. (1996). Emotional support for cancer patients: what do patients really want?. British Journal of Cancer. 74(8). 1275–1279. 127 indexed citations

2.

Seymour, Michel, et al.. (1994). Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease. British Journal of Cancer. 69(1). 191–195. 57 indexed citations

3.

Love, S B, et al.. (1993). Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer. British Journal of Cancer. 67(4). 760–766. 66 indexed citations

4.

Patel, Naina, et al.. (1992). Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide. British Journal of Cancer. 65(1). 122–126. 39 indexed citations

5.

Armes, Jo, et al.. (1992). A study to investigate the incidence of early satiety in patients with advanced cancer. British Journal of Cancer. 65(3). 481–484. 12 indexed citations

6.

Thompson, Paul, Michel Seymour, N. Deasy, et al.. (1991). A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas. British Journal of Cancer. 64(3). 603–605. 33 indexed citations

7.

Malik, Simran & ML Slevin. (1991). Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary - a new therapeutic approach?. British Journal of Cancer. 63(3). 410–411. 27 indexed citations

8.

Malik, Simran, et al.. (1990). Phase II trial of UFT in advanced colorectal and gastric cancer. British Journal of Cancer. 62(6). 1023–1025. 52 indexed citations

9.

Slevin, ML, et al.. (1988). Who should measure quality of life, the doctor or the patient?. British Journal of Cancer. 57(1). 109–112. 743 indexed citations breakdown →

10.

Ward, B, S. J. Mather, J. Shepherd, et al.. (1988). The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy. British Journal of Cancer. 58(5). 658–662. 34 indexed citations

11.

Slevin, ML, et al.. (1988). Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. British Journal of Cancer. 57(1). 115–116. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact